| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine, Division of Pulmonary and Critical Care (Drs. Dewan, Rafique, Kanwar, and Satpathy) and Division of Cardiology (Ms. Ryschon), Creighton University and Veterans Affairs Medical Center, Omaha, NE; Pulmonary and Critical Care Medicine (Dr. Niederman), Winthrop University Hospital, Mineola, NY; and Bayer Pharmaceutical Division (Mr. Tillotson), West Haven, CT.
Correspondence to: Naresh A. Dewan, MBBS, FCCP, Associate Professor, Division of Pulmonary and Critical Care, Department of Internal Medicine, Creighton University, St. Joseph Hospital, 601 North 30th St, Omaha, NE 68131; e-mail: ndewan{at}creighton.edu
Objectives: To determine the effect of age, severity of lung disease, severity and frequency of exacerbation, steroid use, choice of an antibiotic, and the presence of comorbidity on the outcome of treatment for an acute exacerbation of COPD.
Design: A retrospective chart analysis over 24 months.
Setting: A university Veterans Affairs medical center.
Patients: Outpatients with COPD who were treated with an antibiotic over a period of 24 months for an acute exacerbation of COPD.
Methods: Severity of an acute exacerbation of
COPD was defined using the criteria of Anthonisen et al: increased
dyspnea, increased sputum volume, and increased sputum purulence.
Severity of lung disease was stratified based on FEV1
percent predicted using American Thoracic Society guidelines
(stage I, FEV1 
50%; stage II, FEV1 35 to
49%; stage III, FEV1 < 35%). Treatment outcome was
judged successful when the patient had no return visit in 4 weeks for a
respiratory problem. Failure was defined as a return visit for
persistent respiratory symptoms that required a change of an antibiotic
in < 4 weeks.
Results: One-hundred seven patients with COPD (mean age ± SD, 66.9 ± 9.5 years) experienced 232 exacerbations over 24 months. First-line antibiotics (trimethoprim-sulfamethoxazole, ampicillin/amoxicillin, and erythromycin) were used to treat 78% of all exacerbations. Treatment failure was noted in 12.1% of first exacerbations and 14.7% of all exacerbations, with more than half the failures requiring hospitalization. Host factors that were independently associated with treatment failure included the following: FEV1 < 35% (46.4% vs 22.4%; p = 0.047), use of home oxygen (60.7% vs 15.6%; p < 0.0001), frequency of exacerbation (3.8 ± 2.0 vs 1.6 ± 0.91; p < 0.001), history of previous pneumonia (64.3% vs 35.1 p < 0.007), history of sinusitis (28.6% vs 8.8%; p < 0.009) and use of maintenance steroids (32.1% vs 15.2% p = 0.052). Using stepwise logistic regression analysis to identify the top independent variables, the use of home oxygen (p = 0.0002) and frequency of exacerbation (p < 0.0001) correctly classified failures in 83.3% of the patients. Surprisingly, age, the choice of an antibiotic, and the presence of any one or more comorbidity did not affect the treatment outcome.
Conclusion: The results of our study suggest that patient host factors and not antibiotic choice may determine treatment outcome. Prospective studies in appropriately stratified patients are needed to validate these findings.
Key Words: acute exacerbation • chronic obstructive pulmonary disease • outcome factors
This article has been cited by other articles:
|
|
 |
|
  B. S. Quon, W. Q. Gan, and D. D. Sin Contemporary Management of Acute Exacerbations of COPD: A Systematic Review and Metaanalysis Chest, March 1, 2008; 133(3): 756 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Lee, B. Bartle, and K. B. Weiss Spirometry Use in Clinical Practice Following Diagnosis of COPD Chest, June 1, 2006; 129(6): 1509 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. M. Cano, C. Pichard, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J.-P. Laaban, J.-C. Melchior, J.-C. Raphael, et al. C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure Chest, August 1, 2004; 126(2): 540 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J., June 1, 2004; 23(6): 932 - 946. [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wilson, L. Allegra, G. Huchon, J.-L. Izquierdo, P. Jones, T. Schaberg, and P.-P. Sagnier Short-term and Long-term Outcomes of Moxifloxacin Compared to Standard Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis Chest, March 1, 2004; 125(3): 953 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, C. L. Emerman, R. K. Cydulka, B. H. Rowe, S. Clark, and C. A. Camargo Prospective Multicenter Study of Relapse Following Emergency Department Treatment of COPD Exacerbation Chest, February 1, 2004; 125(2): 473 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Mentzelopoulos, S. G. Zakynthinos, C. Roussos, M. J. Tzoufi, and A. S. Michalopoulos Prone Position Improves Lung Mechanical Behavior and Enhances Gas Exchange Efficiency in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients Anesth. Analg., June 1, 2003; 96(6): 1756 - 1767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Inoue, H. Nakamura, K. Otake, H. Saito, K. Terashita, J. Sato, H. Takeda, and H. Tomoike Impaired Pulmonary Inflammatory Responses Are a Prominent Feature of Streptococcal Pneumonia in Mice with Experimental Emphysema Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 764 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Dewan COPD Exacerbations : To X-ray or Not To X-ray Chest, October 1, 2002; 122(4): 1118 - 1121. [Full Text] [PDF]
|
|
|
|
|
|
D. Lieberman, D. Lieberman, Y. Gelfer, R. Varshavsky, B. Dvoskin, M. Leinonen, and M. G. Friedman Pneumonic vs Nonpneumonic Acute Exacerbations of COPD Chest, October 1, 2002; 122(4): 1264 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G C Donaldson, T A R Seemungal, A Bhowmik, and J A Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax, October 1, 2002; 57(10): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sohy, C. Pilette, M.S. Niederman, and Y. Sibille Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur. Respir. J., May 1, 2002; 19(5): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD* Chest, May 1, 2002; 121(5): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ioanas, J. Angrill, X. Baldo, F. Arancibia, J. Gonzalez, T. Bauer, E. Canalis, and A. Torres Bronchial bacterial colonization in patients with resectable lung carcinoma Eur. Respir. J., February 1, 2002; 19(2): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Eur. Respir. J., May 1, 2001; 17(5): 928 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wilson Bacteria, antibiotics and COPD Eur. Respir. J., May 1, 2001; 17(5): 995 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. McCrory, C. Brown, S. E. Gelfand, and P. B. Bach Management of Acute Exacerbations of COPD : A Summary and Appraisal of Published Evidence Chest, April 1, 2001; 119(4): 1190 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Antibiotic Use Does Not Determine Outcome in COPD Exacerbations Journal Watch Emergency Medicine, May 1, 2000; 2000(501): 18 - 18. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
